Bladder Cancer A Practical Guide
Oncological Monitoring of NonMuscle Invasive Bladder Cancer (NMIBC)
Publication
, Chapter
Golla, V; Chamie, K
January 1, 2021
Bladder cancer is the most common urinary tract malignancy and the fifth leading new cancer diagnosis in the United States. Nonmuscle-invasive bladder cancer (NMIBC) comprises the majority of these cases and is known for its varying oncological outcomes and need for frequent follow-up and treatment. However, there is significant heterogeneity between surveillance protocols and an undefined role for the implementation of new endoscopic technology and urinary markers. This chapter will serve as a comprehensive and practical guide for the oncological monitoring of NMIBC. Additionally, it will incorporate tips and tricks utilized by experts in the field that can be applied in a urologist’s daily practice.
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Golla, V., & Chamie, K. (2021). Oncological Monitoring of NonMuscle Invasive Bladder Cancer (NMIBC). In Bladder Cancer A Practical Guide (pp. 123–138). https://doi.org/10.1007/978-3-030-70646-3_13
Golla, V., and K. Chamie. “Oncological Monitoring of NonMuscle Invasive Bladder Cancer (NMIBC).” In Bladder Cancer A Practical Guide, 123–38, 2021. https://doi.org/10.1007/978-3-030-70646-3_13.
Golla V, Chamie K. Oncological Monitoring of NonMuscle Invasive Bladder Cancer (NMIBC). In: Bladder Cancer A Practical Guide. 2021. p. 123–38.
Golla, V., and K. Chamie. “Oncological Monitoring of NonMuscle Invasive Bladder Cancer (NMIBC).” Bladder Cancer A Practical Guide, 2021, pp. 123–38. Scopus, doi:10.1007/978-3-030-70646-3_13.
Golla V, Chamie K. Oncological Monitoring of NonMuscle Invasive Bladder Cancer (NMIBC). Bladder Cancer A Practical Guide. 2021. p. 123–138.